Skip to main navigationSkip to main content
The University of Southampton
Southampton Health Technology Assessments Centre

Heart disease

Click on the title for more information (where available).

Cooper, K., Picot, J., Onyimadu, O., Shepherd, J., Lord, J., Scott, D., Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease. A Single Technology Appraisal. Southampton Health Technology Assessments Centre (SHTAC), 2018.

Colquitt JL, Mendes D, Clegg AJ, Harris P, Cooper K, Picot J, et al. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation. Health Technology Assessment 2014;18(56)

Hutchinson J, Scott DA, Clegg AJ, Loveman E, Royle P, Bryant J et al. The cost-effectiveness of left ventricular assist devices in end stage heart failure. Expert Review of Cardiovascular Therapy 2008;6(2):175-85.  

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation. Health Technology Assessment 2008;12(28):1-118.  

Bryant J, Brodin H, Loveman E, Clegg A. Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: A systematic review and economic evaluation. International Journal of Technology Assessment in Health Care 2007;23 (1):63-70.  

Clegg AJ, Scott DA, Loveman E, Colquitt J, Royle P, Bryant J. Clinical and cost effectiveness of left ventricular assist devices as destination therapy for people with end stage heart failure: a systematic review and economic evaluation. International Journal of Technology Assessment in Health Care 2007;23(2). 

Clegg A, Scott DA, Loveman E, Colquitt J, Royle P, Bryant J. Clinical and cost effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end stage heart failure: a systematic review and economic evaluation. European Heart Journal 2006;27:2929-38.  

Bryant J, Brodin H, Loveman E, and Clegg A. Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmia: a systematic review and economic evaluation (Poster). HTAi June 2005, Rome. 2005.

Bryant J, Loveman E, Clegg A, Brodin H, Payne E. The clinical effectiveness and cost effectiveness of implantable cardioverter defibrillators: arrhythmias. Health Technology Assessment 2005;9(36).  

Clegg A.J., Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P et al. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Health Technology Assessment 2005;9(45). 

Hartwell D, Colquitt J, Loveman E, Clegg A, Brodin H, Waugh N et al. Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction. Health Technology Assessment2005;9(17).                                                                                                   

Parkes J, Bryant J, Milne R. Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness. Heart 2002;87(5):438-42.  

Privacy Settings